Amid the global pandemic and unprecedented times, the role and responsibilities of Clinical Laboratories have upsurged drastically. It not only plays an essential role in the detection of health-related problems but at the same time assures the timely delivery of quality health care.
To cater to this ever-increasing demand, and with an experience of 16 years, Grupo Cenahce delivers highly reliable laboratory data to satisfy the needs of clinicians involved in medical practices. Being the only company in the country to have a clinical and pathology laboratory, Grupo Cenahce ensures timely delivery alongside higher customer satisfaction.
Under the astonishing leadership of its Founder and Co-owner, Juvenal Feoli, the laboratory has introduced new techniques and has started working closely with endocrinologists and practitioners.
In an interview with Insights Care, Juvenal talks about the 16 years journey of Cenahce and how it is offering the best quality laboratory data in Costa Rica.
Below are the highlights of the Interview.
Please brief our audience about Cenahce Laboratories, its USPs, and how it is currently positioned as a reliable firm in the healthcare sector.
Cenahce Laboratories was created more than 16 years ago as a clinical and reference laboratory for hormones and other tests, covering the demand and ensuring the satisfaction of our customers. Today, we also have a department of Molecular Biology, Pathology, and Cytology, the only private company in the country with a clinical and pathology laboratory.
Cenahce laboratories are what they are today, thanks to the exceptional customer service and trust we generate in patients, doctors, and companies.
Shed some light on your offerings and how they impact the industry and your clients?
Our goal has always been to be the best clinical and pathology laboratory in the country, always looking to offer new analysis, service diversification, and excellent customer service in order to achieve a better diagnosis and grow on a national and international level.
That’s why we have advocated offering a broad range of tests and services starting from Clinical Chemistry tests, Immunology, Hematology, Parasitology, Molecular tests, Karyotyping and Anatomic, Cellular (Cytopathology), and Dermatopathology.
Having this broad range of services gives our patients a unique platform where they can do most of their health care tests and receive a complete follow-up all in the same place. Also, our pathology platform gives our business customers and partners an all-in-one service where the medical professionals can have their services tailored to their needs.
Being an experienced leader, Juvenal, can you share your opinion on how the adoption of modern technologies has impacted the industry and how is your company riding the technology wave?
Modern technologies have revolutionized the way we work, and they are here to stay. In the health sector, technologies help in critical points that affect the patient directly. Automation and new essays, for instance, impact the turnover time in test results, assisting in a fast and reliable diagnosis by the medical practitioners. New technologies also help the research teams to find new molecules, medications, vaccines, or any other breakthrough that directly affects the clinical area.
Cenahce Laboratories always tries to adopt new technologies to diversify and stay ahead in this sector. Departments like Molecular Biology and pathology typically adopt new technologies faster due to the demand for more testing options.
Our Molecular Biology department, for instance, adapted technologies to offer RT-PCR Covid Testing (aside from all the other tests we currently have).
Considering the example of COVID-19, how do you plan to navigate through similar situations in the future?
We have navigated this pandemic the same way, not stopping or turning back. I believe the critical factor that made us go through and grow as a company was the willingness to follow through with the projects that were already on course and adapt fast enough to the Covid testing demand.
What would be your advice to budding entrepreneurs who aspire to venture into the healthcare space?
Be convinced that they are in a field where they can perform and grow. Believe in the project. Harsh times could arrive, and it is imperative to stay focused on the objectives and don’t give up.
How do you envision scaling your organization’s operations and offerings in 2022 and beyond?
Scaling depends on market requirements and offering something that can change the current paradigm and make it necessary. This is something we always have on our minds. The key is diversifying into less exploited areas and creating a niche in the market.
We did this when we opened our Pathology department, making our company the only one with a clinical and pathology lab in the country. As I always say, “the sky is the limit.”
Please give us a few testimonials of your clients/customers and a list of awards/recognitions that accurately highlight your organization’s position in the market.
“Promed Stamp” for excellence in health care in Costa Rica. This stamp is given to the health care companies that collaborate directly with the Costa Rican Chamber of Health.
Graduating as a Microbiologist and Clinical Chemist at the University of Costa Rica, Juvenal Feoli has always committed to the vision to leave a dent in the health sector by helping the end-user, the patient. He completed his Postgraduate studies in Hormones at the Fondation de Recherche en Hormonologie in Fresnes, France.
He published a novel technique to detect Catecholamines (Hormones responsible for the body’s “fight-or-flight” response). He then worked at the National Children’s Hospital as head of the hormone area of the clinical laboratory, where he introduced new techniques and worked closely with all the endocrinologists and practitioners. He has also been invited as visiting professor to lecture Clinical Chemistry classes at the Universidad de Costa Rica.